Publications by authors named "C Zanella"

Background: In pediatric palliative care, the main caregiver is primarily responsible for managing pharmaceutical therapies. Few data are available regarding the influence of this burden on quality of life in terms of time, concerns as well as a considerable risk of administration errors and adverse effects. This study aims to investigate how caregivers prepared and administrated medication, including errors and associated expectations, to identify improvement interventions.

View Article and Find Full Text PDF

Overly fast corrosion degradation of biodegradable magnesium alloys has been a major problem over the last several years. The development of protective coatings by using biocompatible, biodegradable, and non-toxic material such as chitosan ensures a reduction in the rate of corrosion of Mg alloys in simulated body fluids. In this study, chitosan/TiO nanocomposite coating was used for the first time to hinder the corrosion rate of Mg19Zn1Ca alloy in Hank's solution.

View Article and Find Full Text PDF

Despite years of intense investigation, the mechanisms underlying neuronal death in Alzheimer's disease, the most common neurodegenerative disorder, remain incompletely understood. To define relevant pathways, we integrated the results of an unbiased, genome-scale forward genetic screen for age-associated neurodegeneration in with human and Alzheimer's disease-associated multi-omics. We measured proteomics, phosphoproteomics, and metabolomics in models of Alzheimer's disease and identified Alzheimer's disease human genetic variants that modify expression in disease-vulnerable neurons.

View Article and Find Full Text PDF
Article Synopsis
  • Research is exploring whether neurodegenerative diseases caused by similar protein misfolding share genetic risk factors, but traditional studies lack the power to conclusively determine this.
  • By selecting patients based on their specific protein aggregation rather than just their clinical diagnosis, researchers can better identify genetic variants associated with diseases like Parkinson's and Alzheimer's.
  • The study finds that genetic modifiers related to alpha-synuclein and beta-amyloid contribute to shared risk factors in neurodegenerative diseases, indicating common underlying mechanisms across different conditions.
View Article and Find Full Text PDF

Chemotherapy-related cognitive impairment (CRCI) is a common adverse effect of treatment and is characterized by deficits involving multiple cognitive domains including memory. Despite the significant morbidity of CRCI and the expected increase in cancer survivors over the coming decades, the pathophysiology of CRCI remains incompletely understood, highlighting the need for new model systems to study CRCI. Given the powerful array of genetic approaches and facile high throughput screening ability in Drosophila, our goal was to validate a Drosophila model relevant to CRCI.

View Article and Find Full Text PDF